The association of body weight change and regression to normoglycemia in different phenotypes of pre-diabetes: Findings of a longitudinal cohort study

IF 2.9 Q3 NUTRITION & DIETETICS
Zahra Bahadoran , Parvin Mirmiran , Fereidoun Azizi , Farhad Hosseinpanah
{"title":"The association of body weight change and regression to normoglycemia in different phenotypes of pre-diabetes: Findings of a longitudinal cohort study","authors":"Zahra Bahadoran ,&nbsp;Parvin Mirmiran ,&nbsp;Fereidoun Azizi ,&nbsp;Farhad Hosseinpanah","doi":"10.1016/j.clnesp.2024.08.024","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><p>We investigated the association of a 3-year change in body weight (BW) and regression to normal glucose regulation (NGR) among different phenotypes of pre-diabetes (Pre-DM), i.e., isolated impaired glucose tolerance (iIGT), isolated impaired fasting glucose (iIFG) and combined IFG-IGT.</p></div><div><h3>Research design and methods</h3><p>1458 Pre-DM subjects (iIFG = 618, iIGT = 462, and IFG-IGT = 378) were assessed for 3-year change-percent in BW (2006–2008 to 2009–2011) and then followed up to 2015–2017, within the national cohort of Tehran Lipid and Glucose Study (TLGS). Binary logistic regression models were used to estimate the probability (odds ratio, ORs) of regression to NGR across categories of 3-year BW change (i.e., ≥5% BW loss, &lt;5% BW loss, BW gain) in different phenotypes of Pre-DM.</p></div><div><h3>Results</h3><p>The mean age of the participants was 53.0 ± 13.7, and 46.8% were men. Over a median of 6 years of follow-up, the rate of regression to normoglycemia was 50.6, 43.2, and 12.7% in iIGT, iIFG, and combined IFG-IGT, respectively. The baseline-adjusted mean of 3-year BW change was not significantly different across Pre-DM phenotypes (0.68 ± 0.19, 0.32 ± 0.22, and 0.23 ± 0.24 kg, in iIFG, iIGT, and IFG-IGT). Three-year BW loss ≥5% was associated with a greater NGR probability in iIGT than other phenotypes (OR = 4.29 <em>vs.</em> 3.90 and 2.84 in IFG-IGT and iIFG, respectively). A modest reduction (&lt;5% of initial BW) resulted in an increased chance of Pre-DM regression among subjects with iIGT (OR = 1.61, 95% CI = 1.03–2.52) but not iIFG or IFG-IGT phenotypes.</p></div><div><h3>Conclusion</h3><p>Short-term intensive BW loss (≥5% of initial BW) increased NGR probability in all Pre-DM phenotypes, with an order of iIGT &gt; combined IFG-IGT &gt; iIFG. Only iIGT takes advantage of moderate BW loss (&lt;5% of initial BW) to increase the chance of Pre-DM regression.</p></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"63 ","pages":"Pages 887-892"},"PeriodicalIF":2.9000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457724012944","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

We investigated the association of a 3-year change in body weight (BW) and regression to normal glucose regulation (NGR) among different phenotypes of pre-diabetes (Pre-DM), i.e., isolated impaired glucose tolerance (iIGT), isolated impaired fasting glucose (iIFG) and combined IFG-IGT.

Research design and methods

1458 Pre-DM subjects (iIFG = 618, iIGT = 462, and IFG-IGT = 378) were assessed for 3-year change-percent in BW (2006–2008 to 2009–2011) and then followed up to 2015–2017, within the national cohort of Tehran Lipid and Glucose Study (TLGS). Binary logistic regression models were used to estimate the probability (odds ratio, ORs) of regression to NGR across categories of 3-year BW change (i.e., ≥5% BW loss, <5% BW loss, BW gain) in different phenotypes of Pre-DM.

Results

The mean age of the participants was 53.0 ± 13.7, and 46.8% were men. Over a median of 6 years of follow-up, the rate of regression to normoglycemia was 50.6, 43.2, and 12.7% in iIGT, iIFG, and combined IFG-IGT, respectively. The baseline-adjusted mean of 3-year BW change was not significantly different across Pre-DM phenotypes (0.68 ± 0.19, 0.32 ± 0.22, and 0.23 ± 0.24 kg, in iIFG, iIGT, and IFG-IGT). Three-year BW loss ≥5% was associated with a greater NGR probability in iIGT than other phenotypes (OR = 4.29 vs. 3.90 and 2.84 in IFG-IGT and iIFG, respectively). A modest reduction (<5% of initial BW) resulted in an increased chance of Pre-DM regression among subjects with iIGT (OR = 1.61, 95% CI = 1.03–2.52) but not iIFG or IFG-IGT phenotypes.

Conclusion

Short-term intensive BW loss (≥5% of initial BW) increased NGR probability in all Pre-DM phenotypes, with an order of iIGT > combined IFG-IGT > iIFG. Only iIGT takes advantage of moderate BW loss (<5% of initial BW) to increase the chance of Pre-DM regression.

不同表型糖尿病前期患者体重变化与血糖恢复正常之间的关系:一项纵向队列研究的结果。
目的:我们研究了糖尿病前期(Pre-DM)不同表型,即孤立糖耐量受损(iIFG)、孤立空腹血糖受损(iIGT)和联合IFG-IGT,体重(BW)的3年变化与回归正常血糖调节(NGR)之间的关联、研究设计和方法:在德黑兰血脂和血糖研究(TLGS)的全国队列中,对 1458 名糖尿病前期受试者(iIFG=618 人、iIGT=462 人和 IFG-IGT=378 人)进行了体重 3 年变化百分比评估(2006-2008 年至 2009-2011 年),然后随访至 2015-2017 年。二元逻辑回归模型用于估算不同表型的前期糖尿病患者3年体重变化类别(即体重减轻≥5%、体重减轻0-5%、体重增加)回归到NGR的概率(几率比,OR):参与者的平均年龄为(53.0±13.7)岁,46.8%为男性。在中位 6 年的随访中,iIGT、iIFG 和 IFG-IGT 组合的血糖恢复正常率分别为 50.6%、43.2% 和 12.7%。经基线调整的 3 年体重变化平均值在不同的 DM 前表型中没有显著差异(iIFG、IGT 和 IFG-IGT 分别为 0.68±0.19、0.32±0.22 和 0.23±0.24kg)。与其他表型相比,iIGT 三年体重下降≥5% 与更高的 NGR 概率相关(OR=4.29 vs. IFG-IGT 和 iIFG 分别为 3.90 和 2.84)。在 IGT 受试者中,适度减少体重(初始体重的 0%-5%)会增加 DM 前回归的几率(OR=1.61,95% CI=1.03-2.52),但在 iIFG 或 IFG-IGT 表型中不会:结论:短期集中减重(≥初始体重的 5%)会增加所有 DM 前表型的 NGR 概率,其顺序为 iIGT> 综合 IFG-IGT>iIFG。只有 iIGT 能利用中度体重损失(初始体重的 0-5%)来增加前期 DM 退化的几率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical nutrition ESPEN
Clinical nutrition ESPEN NUTRITION & DIETETICS-
CiteScore
4.90
自引率
3.30%
发文量
512
期刊介绍: Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信